- Open Access
Plasmodium vivax msp-3α polymorphisms: analysis in the Indian subcontinent
© The Author(s) 2016
- Received: 15 April 2016
- Accepted: 6 September 2016
- Published: 23 September 2016
Plasmodium vivax is the most widely distributed human malaria parasite and accounts for approximately the same number of malaria cases as Plasmodium falciparum in India. Compared with P. falciparum, P. vivax is difficult to eradicate because of its tendency to cause relapses, which impacts treatment and control strategies. The genetic diversity of these parasites, particularly of the merozoite surface protein-3 alpha (msp-3α) gene, can be used to help develop a potential vaccine. The present study aimed to investigate the genetic diversity of P. vivax using the highly polymorphic antigen gene msp-3α and to assess the suitability of using this gene for population genetic studies of P. vivax isolates and was carried out in 2004–06. No recent study has been reported for MSP 3α in the recent decade in India. Limited reports are available on the genetic diversity of the P. vivax population in India; hence, this report aimed to improve the understanding of the molecular epidemiology of the parasite by studying the P. vivax msp-3α (Pvmsp-3α) marker from P. vivax field isolates from India.
Field isolates were collected from different sites distributed across eight states in India. A total of 182 blood samples were analysed by a nested polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique using the HhaI and AluI restriction enzymes to determine genetic msp-3α variation among clinical P. vivax isolates.
Based on the length variants of the PCR products of Pvmsp-3α gene, three allele sizes, Type A (1.8 kb), Type B (1.5 kb) and Type C (1.2 kb) were detected among the 182 samples. Type A PCR amplicon was more predominant (75.4 %) in the samples compared with the Type B (14.3 %) and Type C (10.0 %) polymorphisms. Among all of the samples analysed, 8.2 % were mixed infections detected by PCR alone. Restriction fragment length polymorphism (RFLP) analysis involving the restriction enzymes AluI and HhaI generated fragment sizes that were highly polymorphic and revealed substantial diversity at the nucleotide level.
The present study is the first extensive study in India using the Pvmsp-3α marker. The results indicated that Pvmps-3α, a polymorphic genetic marker of P. vivax, exhibited considerable variability in infection prevalence in field isolates from India. Additionally, the mean multiplicity of infection observed at all of the study sites indicated that P. vivax is highly diverse in nature in India, and Pvmsp-3α is likely an effective and promising epidemiological marker.
- Plasmodium vivax
- Merozoite surface protein-3α
- Genetic variability
Plasmodium vivax is the most widely spread human malaria parasite, infecting 22 million people each year outside of sub-Saharan Africa. Plasmodium vivax has a firm hold in South and Southeast Asia, where it accounts for 80 % of the total estimated cases from three countries: India, Indonesia and Pakistan . Although P. vivax malaria is acute and excruciating, it is considered a benign form of tertian fever with fewer complications compared with Plasmodium falciparum . However, recent evidence has indicated the occurrence of complicated vivax malaria cases, especially in Asia [3, 4]. The problem is further compounded by the emergence of drug resistance in vivax malaria [5–12]. The partial effectiveness of drug treatments and subsequent recurrent infections contribute to severe anaemia from vivax malaria .
In India, high endemicity in conjunction with the dense population contributes to the burden of vivax malaria, leading to vast social and economic consequences. Recent reports indicated equal prevalence of both P. vivax and P. falciparum in India . Despite its prevalence, the lack of knowledge regarding global endemicity is a major hindrance to controlling vivax malaria . Investigating the parasite population structure for genetic polymorphisms could aid in understanding the role of genetic diversity in malaria transmission  and is essential for the control and elimination of malaria .
Despite the high prevalence of P. vivax, few studies have investigated the genetic diversity of natural P. vivax populations in India. The P. vivax genome exhibits greater diversity compared with P. falciparum  and displays high levels of antigenic polymorphisms, which indicates the presence of sophisticated mechanisms to evade the human immune system . However, recurrent infections that arise from recrudescence, re-infection or relapses make it difficult to interpret the results of clinical P. vivax studies that aim to determine the efficacy of treatment strategies.
Elucidating the genetic diversity of Indian P. vivax isolates using antigenic markers could augment the understanding of the biology and epidemiology of P. vivax. Additionally, understanding host genetics and environmental conditions will further aid in developing strategies for the effective control of malaria. To date, a number of single-copy antigenic genetic markers have been tested and reported for Indian isolates [20–24].
The gene of the P. vivax merozoite surface protein-3 alpha (Pvmsp-3α) is one of the most commonly characterized molecular markers in P. vivax genotyping studies. Pvmsp-3α is a potentially an important vaccine candidate expressed on the merozoite surface of the parasite and encodes a protein with three blocks of alanine-rich domain containing heptad repeats and is predicted to form α-helical coiled-coil tertiary structures . Sequence polymorphism is concentrated in the central domain and can comprise of numerous point mutations and large insertions and deletions [26, 27]. These polymorphisms confer antigenic diversity in Pvmsp-3α; however, the alanine-rich heptad repeats, which are predicted to form an intramolecular coiled-coil, are conserved . The msp3 paralogs from P. vivax show weak similarity to msp3 gene family members on P. falciparum . Although both PfMSP-3 and PvMSP-3 protein contain blocks of alanine-rich heptad repeats followed by an acidic C-terminus , there is no supporting evidence of msp3 family of P. falciparum being a homologue to that of P. vivax . In India, this polymorphic marker has been characterized in Kolkata, which is a hypo-endemic region , and in Chennai, which exhibits variable endemicity  and extensive polymorphisms in the single-copy gene and encoded protein. High genetic diversity in this locus has also been reported in South and Southeast Asian countries, including Korea , Nepal , Pakistan [33, 34], Bangladesh , Sri Lanka  and Thailand .
Studying the pattern of variation and distribution of Pvmsp-3α polymorphisms in different blocks of MSP-3α among isolates of South Asia and around the world will aid in understanding of the evolutionary mechanisms underlying variation patterns . Studies on genetic variation in different regions with malaria have revealed numerous alleles and specific variants in different MSP-3α blocks. Additionally, the allelic forms in different blocks were observed in diverse populations worldwide [39–43]. PvMSP3α is composed of four regions which include an N-terminal signal sequence, polymorphic alanine rich repeat region as block I, less variable region as block II and an acidic C-terminus. Deletion within block I region is the basis of size polymorphism in msp-3α whereas in block II, the variations was clustered around the two structural motifs (motif I: MSELEK/LSKLEE and motif II: TAANVVKD/KEATAAKL) [26, 38, 44]. Among different populations block II was found to be relatively conserved with synonymous and non-synonymous mutations. Synonymous mutations were seen in low frequency and were population specific however, non-synonymous mutations were extensively shared among different parasite populations . Restriction fragment length polymorphism (RFLP) analysis was used to determine the diversity of this gene using sequenced representative isolates. Patterns and levels of genetic diversity provide insight into population structure and aid in testing for balancing or negative selection acting on this gene.
Analysing P. vivax population structure is fundamental to understanding the role of genetic diversity in the transmission of malaria. Moreover, knowledge of the magnitude of the genetic polymorphisms within P. vivax populations is an important element for the development of strategies to effectively control malaria . Pvmsp-3α is a potential antigen for vaccine development, as indicated by a study of small children in a malaria-endemic region, Papua New Guinea (PNG) . Variation in the msp-3α allelic patterns of P. vivax in India provides fundamental knowledge for inferring P. vivax population structure and therefore information that can be used to help design MSP-3-based malaria vaccines.
In this paper the extent of allelic and sequence diversity in Pvmsp-3α in field isolates collected from different geographical regions of India with varied malaria transmission patterns was investigated. To accomplish this, isolates from different endemic areas were collected and amplified by nested polymerase chain reaction (PCR) and analysed using PCR-RFLP analysis.
The blood smears were stained with Jaswant Singh Bhattacharya stain  and examined under 1000× magnification. The samples collected were spotted onto autoclaved Whatman filter paper (3 mm) strips, and dried blood spots were stored at 4 °C in plastic bags prior to the extraction of parasite DNA. The study was approved by the ethics committee of the National Institute of Malaria Research. Informed consent was obtained from all adult participants and from the legal guardians of minors.
Genomic DNA isolation
Extraction of parasite genomic DNA from individual dried blood spots on Whatman filter paper strips was carried out using the QiAamp DNA extraction mini kit (Qiagen, Hilden, Germany) based on the manufacturer’s instructions. Extracted samples were re-dissolved in 100 μl triple-distilled autoclaved water and used as a template for PCR amplification or stored at −20 °C until use.
Pvmsp-3α PCR analysis
Plasmodium vivax genotyping was carried out using a nested PCR assay. The protocols used for the PCR assays were reported by Bruce et al. . A 5-µl aliquot of each PCR product was visualized on a 1 % agarose gel (Boehringer Mannheim, Indianapolis, USA). Only the samples showing single a PCR fragment were considered for RFLP analysis.
Characterization of the allelic patterns of the 167 PCR single clone isolates obtained was performed using the AluI and HhaI restriction enzymes based on the methods reported by Bruce et al. . To determine the level of Pvmsp-3α polymorphism, RFLP analysis was carried out using the HhaI and AluI restriction enzymes (NEB, Inc, Beverly, MA, USA) in a 10-µL reaction volume. A 5-µl aliquot of each PCR product was digested individually with the restriction enzymes along with BSA in the buffer supplied with the enzymes at 37 °C for 4 h. The restriction products were then visualized on a 3.0 % agarose gel.
Twenty isolates that represented all three of the variants were sequenced and subjected to restriction pattern analysis. These included six samples each of Type B and C and 8 samples of Type A. Conserved primers were designed for nested PCR amplifications to target the block-I, beta, and block-II regions that covered the entire alanine-rich region of Pvmsp-3α , which corresponded to nucleotide positions 205 bp to 2,100 bp (69–700 aa) of the Belem strain . The nested PCR products that were sequenced were subjected to in silico simulation using a restriction mapper  to map the restriction sites and generate fragment sizes. The amplified PCR products from a limited number of isolates from each area were sequenced using the BigDye® terminator cycle sequencing Kit (Applied Biosystems, Foster City, CA, USA) and the ABI Prism® 310 Genetic Analyzer (Applied Biosystems). Curation was performed using the ABI Prism® sequence analysis software (version 3.4, Applied Biosystems). Six internal primers were designed using the Belem strain as a standard to cover the 1.8-kb length and sequenced in both directions for accuracy. The following primers were used: sense strand primers, including Pvmsp3α_F1, 5′-CCGGAAATGCCAACAA-3′; Pvmsp3α_F2, 5′-CAAAGGCGGAAGTGCTGAAC-3′;Pvmsp3α_F3: 5′-GAGAAAAAGCAGAAAA.
GGTAGGAG-3′; and anti-sense primers, including Pvmsp3α_R1, 5′-CCGCCTTTTCCTTTGCCTTAATTTG-3′; Pvmsp3α_R2, 5′-GCCTTTTCTG CCTGCTTCTTA-3′; and Pvmsp3α_R3, 5′-TGCTTTATTTTTAGTTTCTTGTGG-3′. In addition, two nested primers, N1 and N2, were used as described by Bruce et al. .
Pvmsp-3α sequence and phylogenetic analysis
The resulting nucleotide sequences, amino acid sequences that were subsequently deduced from the nucleotide sequences, and multiple sequence alignments were analysed using MEGA 6.06 [50, 51], and the aligned sequences were analysed for phylogenetic inference. To determine the details of Pvmsp-3α sequence diversity, PCR products of 20 samples were aligned with the Belem I reference gene (AF093584) and Salvador I sequence (AAO20890). Restriction site analysis of the Pvmsp-3α sequences from various geographical regions was carried out using restriction-mapping software . The Indian isolates were also compared with 80 published Pvmsp-3α sequences from isolates from different geographic locations including India (KC935446, AF491957, HQ328853-55), Bangladesh (AF491951, AAO20882), Sri Lanka (AF491961 and GU175269-72), Pakistan (AY266090), Thailand (AY833010-26), North Korea (AF491958), South Korea (EF204144-63), Myanmar (EU430576-86), PNG (AF491950, AF491959), Borneo AY118174), Venezuela (KC935422-26), Ecuador (AF491952), Belem (AF093584), and Sal_I (AAO20890). Evolutionary relationships of the Indian isolates and published Pvmsp-3α sequences were determined based on the construction of a phylogenetic tree of nucleotide sequences using the reference strains and the maximum likelihood method, which is based on the Kimura two-parameter distance estimation method  using Mega 6.06. To obtain a confidence value for the aligned sequence dataset, bootstrap analysis of 1000 replications was conducted using Mega 6.06.
Study has clearance of Ethics committee of National Institute of Malaria Research.
Pvmsp3-α allelic frequency
Distribution of the three Pvmsp-3α haplotypes among the Indian states based on PCR and RFLP analysis
PCR based single clones
PCR based multiple clones
PCR-RFLP based single clones
PCR-RFLP based MOI
Navi Mumbai, Maharashtra
Mixed-genotype infections or multiplicity of infections (MOI) were detected based on the size of the polymorphism. Samples were designated as mixed infections when the PCR analysis resulted in two or more products of different size or when the RFLP analysis of a single PCR band exceeded the size of the uncut PCR band. Among all of the samples analysed, 8.2 % (15/182) were mixed Pvmsp-3α infections detected by PCR alone. RFLP analysis was also carried out to detect mixed infections. The total number of multiple clones detected by RFLP and PCR was 22.4 % (41/182). However, RFLP analyses for detecting multiple clones is challenging and needs to be dealt with caution as incomplete digestion may result in pseudo bands. The highest number of multiple infections detected by PCR was in the Chennai (20.5 %) and Rourkela (20 %) samples (7/34 and 2/10, respectively) (Table 1).
Pvmsp-3α PCR-RFLP analysis
Isolates that contained a single allele, as determined by PCR, were further analysed by PCR-RFLP, but mixed infection cases were excluded. The HhaI restriction enzyme showed clear patterns in 139 out of the 167 samples digested (Additional file 1). In total, 26/167 samples (15.5 %) exhibited fragment sizes greater than the PCR fragment and inconsistent fragment patterns. These fragments were possibly multiple-clone infections and not included in the analysis. The PCR-RFLP patterns from 141 samples revealed 56 different alleles using the HhaI restriction enzyme (Additional file 1). The most prevalent alleles were H1 for the Type C haplotype, H2 for the Type B haplotype, and H3, H9, H17, H25 and H33 for the Type A haplotype, which were present in approximately 43.5 % (61/140) of the isolates. (Additional file 1: Figure S1, Additional file 2: Table S1, Additional file 3: Table S2). The genotypic combinations of the AluI and HhaI enzymes were most diverse in the Type A variant, followed by the 1.4-kb variant.
Sequencing of 20 isolates revealed that, among the Indian isolates, the length of the Type A variant ranged from 1883 to 1938 bp, whereas the length of the Type B variant ranged from 1452 to 1461 bp and the length of the Type C variant ranged from 1128 to 1137 bp. Digestion of the three variants with HhaI revealed that a 1-kb fragment was conserved in almost all three of the variants (Additional file 1). This band was observed to be slightly polymorphic on gels following electrophoresis, and sequencing data revealed that the fragment size ranged between 929 and 989 bp. Very few restriction patterns obtained with the AluI enzyme were identical or even similar for closely situated geographical regions, which indicates that the higher resolution of the bands obtained by actual restriction digestion resulted in numerous alleles observed among the Indian isolates.
Pvmsp-3α sequence comparison
Malaria remains the most devastating global human parasitic infection, and in 2015, about 214 million malaria cases and an estimated 438,000 malaria deaths were reported . Additionally, the incidence of malaria in India accounted for 58 % of cases in the South Asian region . P. vivax is the most geographically widespread human malaria parasite, and it annually accounting for 70–80 million clinical cases throughout tropical and sub-tropical regions worldwide. In India, P. vivax causes approximately 42–45 % of all malaria infections .
To develop and evaluate suitable novel control strategies against this parasite, it is important to know the extent of the polymorphisms that exist in the population. Despite more than a century of efforts to eradicate or control malaria, parasite diversity and the genetic variability of the Plasmodium parasites has made it difficult to eradicate this disease. The variability in the polymorphic markers impairs the effectiveness of antibody repertoires generated during previous infections and also hinders development and testing of new drugs and malaria vaccines . This study was carried out with the intention to further understanding of the genetic structure and estimate the extent of the diversity that exists in Pvmsp-3α among the isolates of the Indian subcontinent.
Observations in the present study revealed that Pvmsp-3α was a highly diverse and polymorphic marker among the field isolates in India. Analysis of 182 field isolates collected from eight different locations showed different epidemiological patterns, which indicated extensive and diverse variation. A high degree of allelic diversity previously reported by Kim et al.  among the isolates of Kolkata (India), an area with low transmission of malaria, supports the highly diverse and polymorphic nature of Pvmsp-3α among Indian isolates. It is interesting to note that there was no significant difference in the observed level of diversity among the isolates of low and high endemic regions of the Indian sub-continent. Similar observations of high diversity among isolates of low-endemic areas in Thailand were made by Cui et al. . It is suspected that either highly virulent isolates are not present despite high diversity or the malaria control measures in such regions are more effective for restricting the incidence to a low level.
All three of the Pvmsp-3α PCR variants (Type A, B and C) observed worldwide were present among the field isolates, although with varied frequencies in the different geographical regions. The largest size variant (Type A) occurred at the highest frequency in all samples of natural P. vivax populations in India, and the frequencies observed were similar to the previously reported global frequencies. The difference in the proportion of the Type A and C variants in the population might have been due to the deletions found in the smaller length variants, which might have caused a loss of fitness for the parasites that carried the variants . However, these genotypes may occur in the population to balance any fitness cost associated with large deletions within Pvmsp-3α . Block-I exhibits maximum sequence variability in this region, acts as a placeholder to mimic the larger length variant  and also confers a selective advantage to the parasite, i.e., evasion of preexisting immune responses. The observation that block-II exhibits only slight variation in size and very little polymorphism that is limited to certain portions indicates that it plays an important role in the formation of the protein structure. The Type B and Type C variants exhibited minimal sequence diversity and differed from each other in the nucleotide sequences that form the beta helix turn.
Analysis of the isolates from eight regions of the Indian sub-continent indicated that diversity was not linked to geographical region and a high level of diversity was observed within the same region. New alleles identified in the Indian isolates demonstrated high variability among the field isolates. The high allelic diversity of Pvmsp-3α has also been reported in other regions of the globe, including South Asia, Southeast Asia, PNG  and Latin America , including Peru  and Colombia . Some of the identified alleles are consistent with those from earlier reports, which indicate global distribution of certain parasite genotypes . Based on msp-3α data, the existence of a common allelic composition in different parts of the globe indicates the presence of a single random-mating population of P. vivax across the globe with no geographical sub-structuring. However, this may not be true as new molecular approaches such as microsatellite and mitochondrial studies have been used to assess P. vivax quantifying parasite diversity and population structure [16, 60–62]. HhaI digestion revealed 56 alleles and H1 allele was most prominent in the Indian sub-continent and was seen in the Type C variant among the Indian isolates. H1 allele in these variants has been reported from other regions of the world, including those from India [21, 63, 64].
Simultaneous infection of a host by more than one strain of the same parasite is common in malaria and is partially correlated with transmission intensity levels. For P. vivax malaria, the estimated proportion of mixed-strain infections in PNG is 65 % , compared with 43 % reported in India . In recent studies in the Kolkata region of India, 10.6 % of recorded cases were multiple infections . In the present study, 8.2 % of cases were multiple infections based on PCR detection and 22 % based on PCR-RFLP of Pvmsp-3α sequences. RFLP analyses for detecting multiplicity of infection may not be completely reliable as incomplete digestion lead to spurious results. Restriction with multiple enzymes may be helpful in detecting multiple clones by RFLP. Further, microsatellite (MS) markers and SNP’s are reliable and important tools for studying multiplicity of infection (MOI) of malaria parasite infections [28, 67, 68].
Several studies reported extensive microsatellite diversity and high multiplicity of infection in P. vivax in regions of moderate endemicity . The increased multiplicity of P. vivax infection is attributable to the biological features of the P. vivax parasite, such as early gametocytogenesis and relapse . Moreover, the multiplicity of infections is likely to facilitate genetic recombination of parasites, and the generation of novel strains .
The observed high level of Pvmsp-3α diversity among the field isolates was further supported by sequencing data, which revealed that the different genotypes of the sequenced isolates were found throughout the different geographical areas. In particular, the most common variant (Type A) displayed the maximum diversity, which was expected because of the presence of an intact block-IB in this variant, which is the most variable. However, in the smaller length variants (Type B and C), block-IB was either completely or partially deleted, thereby reducing the diversity.
Twenty samples were sequenced, and the restriction sites were analysed. No two resulting AluI or HhaI restriction banding patterns were similar in the Type A haplotype, which indicated the extent of the variability. Most of the isolates sequenced revealed new alleles. Based on the restriction site analysis of the sequenced isolates, it can be concluded that each of the Type A haplotypes isolated was a different allele. However, when restriction sites of the sequenced Type B haplotype (identical pattern on the gel) were analysed, the restriction pattern differed slightly in terms of band size. However, the Type C fragment restriction pattern analysis of the sequenced fragment revealed a similar pattern, thus indicating reduced variability in the smaller types. The in silico restriction site analysis of the published Pvmsp-3α sequences from various geographical regions was carried out using restriction mapping software. The virtual restriction patterns obtained with either the HhaI or AluI enzymes were not analogous to isolates from a single region or close geographical regions, which indicated that higher resolution of the bands obtained by actual restriction mapping could result in numerous alleles, as was obtained from the Indian isolates. This finding signifies the importance of sequence data as a source for estimating the exact variability and its extent among isolates from other areas globally. As reported earlier, higher levels of sequence polymorphism were observed in the region closer to the central alanine-rich domain [28, 40, 48].
Pvmps-3α is an essential polymorphic marker for studying the population structure of P. vivax. Numerous studies from various regions have been carried out to identify the number of Pvmsp-3α alleles using the PCR-RFLP method [20, 21, 32–37, 39–43]. Several investigators have advocated for this method as a means of identifying the variations available in this allele. However, based on the in silico digestion, AluI results in complicated patterns may not be a good enzyme for PCR-RFLP purpose . Virtual digestion of Pvmsp-3α sequences revealed greater variability in terms of the fragment sizes obtained, which was not resolved easily on a gel and could result in reaching a biased conclusion regarding the number of alleles. Moreover, the results may vary depending on the electrophoresis conditions. As proposed by Rice et al. , sequencing may be a better option to determine the sequence-level genetic diversity of the pvmsp-3α gene. Therefore, sequencing analysis is advocated for analysing the extent of the variability generated by the parasite to evade the host immune system and impart a survival advantage to the parasite [28, 69].
PvMSP-3α is a potentially important vaccine candidate expressed on the surface of the merozoite in the parasite . Dual role for PvMSP-3α in both the immunity and pathogenesis of malaria has been suggested . PvMSP-3α is known to elicit a pronounced antibody response against clinical malaria infections reported from PNG . Additionally, it has been established that naturally acquired antibodies against the C-terminal block-II of PvMSP3α are associated with protection from symptomatic vivax malaria .
There is limited information available regarding PvMSP3α sequences from India. Sequence polymorphisms in Indian isolates were mainly clustered at the 5′ regions of the marker, as was seen in other isolates worldwide. However, block-II (residues 434–687aa of Belem strain), the region of the alanine-rich core displays less variability. In an earlier study phylogenic analysis based on sequence variation of 237 world sequences of PvMSP-3α block II region resulted in three robust clusters suggesting extensive gene flow between populations. However these clusters did not reveal any geographical structure. The phylogenic grouping was influenced by sequence variations of two motif (motif I: MSELEK/LSKLEE and motif II: TAANVVKD/KEATAAKL) which suggested selective pressure on these motifs .
In the Belem strain the motifs I and II correspond to position 529–534aa and 576–583aa respectively . Among the Indian isolates, motif I was represented by MSELEK sequence in all the twenty isolates, while motif II exhibited both the sequences at different frequencies. One of the Indian isolates however represented a recombinant type of motif with an amino acid sequence of TEANVAKL, which was seen in the Goan isolate.
Comparison with published nucleotide and protein sequences in NCBI and PlasmaDB using phylogenetic trees of Pvmsp-3α revealed that most subtypes were new alleles. Two distinct clusters, one which included Belem type and the other Salvador I type were formed when the Indian isolates were compared with other isolates worldwide. Genotypes from different geographical areas were distributed in both clusters, which revealed no convincing evidence of geographical grouping based on this marker.
The present study indicates a high degree of genetic diversity in clinical Pvmsp-3α isolates and is remarkably diverse, even within limited geographical areas of the Indian subcontinent. The high prevalence of mixed-clone infections revealed by this marker in the Indian sub-continent likely resulted from a high transmission rate and tropical climate, which offers a suitable environment for vector breeding. The extensive allelic diversity demonstrates Pvmsp-3α to be a very useful molecular marker for distinguishing field isolates. However, further investigation is required to elucidate the diversity and expression of the C-terminal conserved region in field isolates, which will help reveal the potential of this gene as a vaccine candidate.
AV molecular analysis, PCR work, sequencing, manuscript preparation; HJ conception and design of the study, coordination of molecular analysis work; VS, ARA and NV overall co-ordination and guidance. All authors read and approved the final manuscript.
We are thankful to the Indian Council of Medical Research (ICMR) for providing the facilities as well as partially funding the project under the genomics scheme; and thankful to NIMR scientists and staff (Genetics and Molecular Biology Lab) and Field Units for their support and assistance during the study. We express our deep gratitude to Dr Hema Joshi, PI of this project, who passed away in 2010 during the course of this study.
The authors declare that they have no competing interests.
Availability of data and materials
The dataset supporting the conclusions of this article are available with from the authors and will be publicly available on NCBI from January 2017. Requests for data may be submitted to Anju Verma, firstname.lastname@example.org or Dr. Neena Valecha, email@example.com.
Consent for publication
Informed consent was obtained from all adult participants and from the legal guardians of minors for publication of this case report.
Ethical clearance and consent to participate
Study has clearance of Ethics committee of National Institute of Malaria Research.
The project “Genetic diversity of P. falciparum and P. vivax in India using molecular markers” was funded by Indian Council of Medical Research (ICMR) under the genomics scheme in 2002.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. World malaria report 2014. Geneva: World Health Organization; 2014. http://www.apps.who.int/iris/bitstream/10665/144852/2/9789241564830_eng.pdf.
- Naing C, Whittaker MA, Wai VN, Mak JW. Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2014;8:e3071.View ArticlePubMedPubMed CentralGoogle Scholar
- Khattak AA, Venkatesan M, Nadeem MF, Satti HS, Yaqoob A, Strauss K, et al. Prevalence and distribution of human Plasmodium infection in Pakistan. Malar J. 2013;12:297.View ArticlePubMedPubMed CentralGoogle Scholar
- Raza A, Ghanchi NK, Thaver AM, Jafri S, Beg MA. Genetic diversity of Plasmodium vivax clinical isolates from southern Pakistan using pvcsp and pvmsp1 genetic markers. Malar J. 2013;12:16.View ArticlePubMedPubMed CentralGoogle Scholar
- Baird JK, Basri H, Bangs MJ, Subianto B, Patchen LC, Hoffman SL. Resistance to chloroquine by Plasmodium vivax in Irian Jaya Indonesia. Am J Trop Med Hyg. 1991;44:547–52.PubMedGoogle Scholar
- Garg M, Gopinathan N, Bodhe P, Kshirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg. 1995;89:656–7.View ArticlePubMedGoogle Scholar
- Dua VK, Kar PK, Sharma VP. Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health. 1996;1:816–9.View ArticlePubMedGoogle Scholar
- Kshirsagar NA, Gogtay NJ, Rajgor D, Dalvi SS, Wakde M. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay) India. Ann Trop Med Parasitol. 2000;94:189–90.View ArticlePubMedGoogle Scholar
- Singh RK. Emergence of chloroquine-resistant vivax malaria in south Bihar (India). Trans R Soc Trop Med Hyg. 2000;94:327.View ArticlePubMedGoogle Scholar
- Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeno N, et al. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg. 2001;65:90–3.PubMedGoogle Scholar
- Nandy A, Addy M, Maji AK, Bandyopadhyay AK. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India. Ann Trop Med Parasitol. 2003;97:215–20.View ArticlePubMedGoogle Scholar
- Gonçalves LA, Cravo P, Ferreira MU. Emerging Plasmodium vivax resistance to chloroquine in South America: an overview. Mem Inst Oswaldo Cruz. 2014;109:534–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13–36.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh V, Mishra N, Awasthi G, Dash AP, Das A. Why is it important to study malaria epidemiology in India? Trends Parasitol. 2009;25:452–7.View ArticlePubMedGoogle Scholar
- Breman JG, Alilio MS, White NJ. Defining and defeating the intolerable burden of malaria III. Progress and perspectives. Am J Trop Med Hyg. 2007;77(6 Suppl):vi–xi.Google Scholar
- Arnott A, Barry AE, Reeder JC. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination. Malar J. 2012;11:14.View ArticlePubMedPubMed CentralGoogle Scholar
- Eckhoff Philip A. Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model. Malar J. 2012;11:419.View ArticlePubMedPubMed CentralGoogle Scholar
- Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, et al. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet. 2012;44:1046–50.View ArticlePubMedPubMed CentralGoogle Scholar
- Hisaeda H, Yasutomo K, Himeno K. Malaria: immune evasion by parasites. Int J Biochem Cell Biol. 2005;37:700–6.View ArticlePubMedGoogle Scholar
- Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N, et al. Genetic diversity of Plasmodium vivax in Kolkata, India. Malar J. 2006;5:71.View ArticlePubMedPubMed CentralGoogle Scholar
- Prajapati SK, Joshi H, Valecha N. Plasmodium vivax merozoite surface protein-3 [alpha]: a high-resolution marker for genetic diversity studies. J Vector Borne Dis. 2010;47:85–90.PubMedGoogle Scholar
- Rajesh V, Elamaran M, Vidya S, Gowrishankar M, Kochar D, Das A. Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. Exp Parasitol. 2007;116:252–6.View ArticlePubMedGoogle Scholar
- Farooq U, Malla N, Dubey ML. Polymorphism in merozoite surface protein-1 gene in north and northwest Indian field isolates of Plasmodium vivax. Indian J Med Res. 2009;130:736–41.PubMedGoogle Scholar
- Gupta P, Pande V, Das A, Singh V. Genetic polymorphisms in VIR genes among Indian Plasmodium vivax populations. Korean J Parasitol. 2014;52:557.View ArticlePubMedPubMed CentralGoogle Scholar
- Lupas A. Coiled coils: new structures and new functions. Trends Biochem Sci. 1996;21:375–82.View ArticlePubMedGoogle Scholar
- Rayner JC, Huber CS, Feldman D, Ingravallo P, Galinski MR, Barnwell JW. Plasmodium vivax merozoite surface protein PvMSP-2 beta is radically polymorphic through mutation and large insertions and deletions. Infect Genet Evol. 2004;4:309–19.View ArticlePubMedGoogle Scholar
- Rayner JC, Corredor V, Feldman D, Ingravallo P, Iderabdullah F, Galinski MR, et al. Extensive polymorphism in the Plasmodium vivax merozoite surface coat protein MSP-3α is limited to specific domains. Parasitology. 2002;125:393–405.View ArticlePubMedGoogle Scholar
- Rice BL, Acosta MM, Pacheco MA, Carlton JM, Barnwell JW, Escalante AA. The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. Mol Phylogenet Evol. 2014;78:172–84.View ArticlePubMedPubMed CentralGoogle Scholar
- Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455:757–63.View ArticlePubMedPubMed CentralGoogle Scholar
- McColl DJ, Anders RF. Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3). Mol Biochem Parasitol. 1997;90:21–31.View ArticlePubMedGoogle Scholar
- Nam HW, Song KJ, Ahn HJ, Yang Z, Chong CK, Cho PY, et al. Probability of antibody formation against circumsporozoite protein of Plasmodium vivax among Korean malaria patients. Korean J Parasitol. 2014;52:143.View ArticlePubMedPubMed CentralGoogle Scholar
- Adhikari M, Ranjitkar S, Schousboe ML, Alifrangis M, Imwong M, Bhatta DR, et al. Genetic diversity of Plasmodium vivax merozoite surface protein-3alpha (Pvmsp-3alpha) gene in Jhapa District of Nepal. Southeast Asian J Trop Med Public Health. 2012;43:280–6.PubMedGoogle Scholar
- Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G. Genetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of Pakistan. Malar J. 2010;9:112.View ArticlePubMedPubMed CentralGoogle Scholar
- Khan SN, Khan A, Khan S, Ayaz S, Attaullah S, Khan J, et al. PCR/RFLP-based analysis of genetically distinct Plasmodium vivax population of Pvmsp-3α and Pvmsp-3β genes in Pakistan. Malar J. 2014;13:355.View ArticlePubMedPubMed CentralGoogle Scholar
- Kibria MG, Elahi R, Mohon AN, Khan WA, Haque R, Alam MS. Genetic diversity of Plasmodium vivax in clinical isolates from Bangladesh. Malar J. 2015;14:267.View ArticlePubMedPubMed CentralGoogle Scholar
- Schousboe ML, Rajakaruna RS, Amerasinghe PH, Konradsen F, Ord R, Pearce R, et al. Analysis of polymorphisms in the merozoite surface protein-3α gene and two microsatellite loci in Sri Lankan Plasmodium vivax: evidence of population substructure in Sri Lanka. Am J Trop Med Hyg. 2011;85:994–1001.View ArticlePubMedPubMed CentralGoogle Scholar
- Rungsihirunrat K, Chaijaroenkul W, Siripoon N, Seugorn A, Na-Bangchang K. Genotyping of polymorphic marker (MSP3α and MSP3β) genes of Plasmodium vivax field isolates from malaria endemic of Thailand. Trop Med Int Health. 2011;16:794–801.View ArticlePubMedGoogle Scholar
- Gupta B, Reddy BN, Fan Q, Yan G, Sirichaisinthop J, Sattabongkot J, et al. Molecular evolution of PvMSP3α block II in Plasmodium vivax from diverse geographic origins. PLoS ONE. 2015;10:e0135396.View ArticlePubMedPubMed CentralGoogle Scholar
- Cui L, Mascorro CN, Fan Q, Rzomp KA, Khuntirat B, Zhou G, et al. Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand. Am J Trop Med Hyg. 2003;68:613–9.PubMedGoogle Scholar
- Mascorro CN, Zhao K, Khuntirat B, Sattabongkot J, Yan G, Escalante AA, et al. Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3α from the malaria parasite Plasmodium vivax in Thailand. Parasitology. 2005;131:25–35.View ArticlePubMedGoogle Scholar
- Moon SU, Lee HW, Kim JY, Na BK, Cho SH, Lin K, et al. High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar. Acta Trop. 2009;109:30–6.View ArticlePubMedGoogle Scholar
- Nam DH, Oh JS, Nam MH, Park HC, Lim CS, Lee WJ, et al. Emergence of new alleles of the MSP-3α gene in Plasmodium vivax isolates from Korea. Am J Trop Med Hyg. 2010;82:522–4.View ArticlePubMedPubMed CentralGoogle Scholar
- Wickramarachchi T, Premaratne PH, Dias S, Handunnetti SM, Udagama-Randeniya PV. Genetic complexity of Plasmodium vivax infections in Sri Lanka, as reflected at the merozoite-surface-protein-3alpha locus. Ann Trop Med Parasitol. 2010;104:95–108.View ArticlePubMedGoogle Scholar
- Han ET, Song TE, Park JH, Shin EH, Guk SM, Kim TY, et al. Allelic dimorphism in the merozoite surface protein-3α in Korean isolates of Plasmodium vivax. Am J Trop Med Hyg. 2004;71:745–9.PubMedGoogle Scholar
- Cui L, Escalante AA, Imwong M, Snounou G. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 2003;19:220–6.View ArticlePubMedGoogle Scholar
- Stanisic DI, Javati S, Kiniboro B, Lin E, Jiang J, Singh B, et al. Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children. PLoS Negl Trop Dis. 2013;7:e2498.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh J. JSB stain: A review. Indian J Malariol. 1956;10:117–29.PubMedGoogle Scholar
- Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg. 1999;61:518–25.PubMedGoogle Scholar
- Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16:111–20.View ArticlePubMedGoogle Scholar
- WHO. 10 facts of malaria. Geneva: World Health Organization; 2015 http://www.who.int/features/factfiles/malaria/en/).
- Gantait K, Gantait I. Vivax malaria complicated by myocarditis. J Assoc Physicians India. 2013;61:944–5.PubMedGoogle Scholar
- Barry AE, Arnott A. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol. 2014;5:359.View ArticlePubMedPubMed CentralGoogle Scholar
- Ord R, Polley S, Tami A, Sutherland CJ. High sequence diversity and evidence of balancing selection in the Pvmsp3α gene of Plasmodium vivax in the Venezuelan Amazon. Mol Biochem Parasit. 2005;144:86–93.View ArticleGoogle Scholar
- Rayment JH, Forsdyke DR. Amino acids as placeholders. Appl Bioinform. 2005;4:117–30.View ArticleGoogle Scholar
- Sutton PL, Neyra V, Hernandez JN, Branch OH. Plasmodium falciparum and Plasmodium vivax infections in the Peruvian Amazon: propagation of complex, multiple allele-type infections without super-infection. Am J Trop Med Hyg. 2009;81:950–60.View ArticlePubMedPubMed CentralGoogle Scholar
- Cristiano FA, Pérez MA, Nicholls RS, Guerra AP. Polymorphism in the Plasmodium vivax msp 3: gene in field samples from Tierralta, Colombia. Mem Inst Oswaldo Cruz. 2008;103:493–6.View ArticlePubMedGoogle Scholar
- Li YC, Wang GZ, Meng F, Zeng W, He CH, Hu XM, et al. Genetic diversity of Plasmodium vivax population before elimination of malaria in Hainan Province, China. Malar J. 2015;14:78.View ArticlePubMedPubMed CentralGoogle Scholar
- Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, et al. The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas. Mol Biol Evol. 2013;30:2050–64.View ArticlePubMedPubMed CentralGoogle Scholar
- Koepfli C, Rodrigues PT, Antao T, Orjuela-Sanchez P, Van den Eede P, Gamboa D, et al. Plasmodium vivax diversity and population structure across four continents. PLoS Negl Trop Dis. 2015;9:e0003872.View ArticlePubMedPubMed CentralGoogle Scholar
- Jennison C, Arnott A, Tessier N, Tavul L, Koepfli C, Felger I, et al. Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations. PLoS Negl Trop Dis. 2015;9:e0003634.View ArticlePubMedPubMed CentralGoogle Scholar
- Zakeri S, Barjesteh H, Djadid ND. Merozoite surface protein-3α is a reliable marker for population genetic analysis of Plasmodium vivax. Malar J. 2006;5:53.View ArticlePubMedPubMed CentralGoogle Scholar
- Maneerattanasak S, Gosi P, Krudsood S, Tongshoob J, Lanteri CA, Snounou G, et al. Genetic diversity among Plasmodium vivax isolates along the Thai–Myanmar border of Thailand. Malar J. 2016;15:75.View ArticlePubMedPubMed CentralGoogle Scholar
- Kolakovich KA, Ssengoba A, Wojcik K, Tsuboi T, Al-Yaman F, Alpers M, et al. Plasmodium vivax: favored gene frequencies of the merozoite surface protein-1 and the multiplicity of infection in a malaria endemic region. Exp Parasitol. 1996;83:11–8.View ArticlePubMedGoogle Scholar
- Joshi H, Valecha N, Verma A, Kaul A, Mallick PK, Shalini S, et al. Genetic structure of Plasmodium falciparum field isolates in eastern and north–eastern India. Malar J. 2007;6:60.View ArticlePubMedPubMed CentralGoogle Scholar
- Koepfli C, Ross A, Kiniboro B, Smith TA, Zimmerman PA, Siba P, et al. Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea. PLoS Negl Trop Dis. 2011;5:e1424.View ArticlePubMedPubMed CentralGoogle Scholar
- Koepfli C, Colborn KL, Kiniboro B, Lin E, Speed TP, Siba PM, et al. A high force of Plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in Papua New Guinean Children. PLoS Negl Trop Dis. 2013;7:e2403.View ArticlePubMedPubMed CentralGoogle Scholar
- Baniecki ML, Faust AL, Schaffner SF, Park DJ, Galinsky K, Daniels RF, et al. Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections. PLoS Negl Trop Dis. 2015;9:0003539.View ArticleGoogle Scholar
- Arévalo-Herrera M, Chitnis C, Herrera S. Current status of Plasmodium vivax vaccine. Human Vaccines. 2010;6:124–32.View ArticlePubMedGoogle Scholar
- Mourão LC, Morais CG, Bueno LL, Jimenez MC, Soares IS, Fontes CJ, et al. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1 19 and Pvmsp-3α 359–798) and their relationship with hematological features in malaria patients from the Brazilian Amazon. Microb Infect. 2012;14:730–9.View ArticleGoogle Scholar